Finance

Lists
600161:SHA
Beijing Tiantan Biological Products Corp
CNÂ¥12.28
+0.74%
(+0.090) 1D
Sep 4, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600161...
Open
CNÂ¥12.25
High
CNÂ¥12.38
Low
CNÂ¥12.16
Mkt. cap
24.28B
Avg. vol.
14.03M
Volume
8.40M
Dividend
1.63%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 24, 2026
P/E ratio
32.07
52-wk high
CNÂ¥20.17
52-wk low
CNÂ¥11.12
EPS
CNÂ¥0.38
Shares outstanding
871.14M
No. of employees
5K
Open
CNÂ¥12.25
High
CNÂ¥12.38
Low
CNÂ¥12.16
Mkt. cap
24.28B
Avg. vol.
14.03M
Volume
8.40M
Dividend
1.63%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 24, 2026
P/E ratio
32.07
52-wk high
CNÂ¥20.17
52-wk low
CNÂ¥11.12
EPS
CNÂ¥0.38
Shares outstanding
871.14M
No. of employees
5K
About Beijing Tiantan Biological Products Corp
CEO-
Employees5.2K
Founded1966
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.35B
1.70B
1.14B
1.45B
Cost of goods sold
803.48M
981.89M
746.78M
914.44M
Cost of revenue
803.48M
981.89M
746.78M
914.44M
Research and development expenses
46.23M
56.84M
39.19M
32.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158.23M
164.29M
139.41M
157.07M
Operating expense
223.23M
268.36M
174.79M
222.17M
Total operating expenses
1.03B
1.25B
921.56M
1.14B
Operating income
327.97M
452.71M
220.14M
317.05M
Other non operating income
-5.26M
3.10M
-860.04K
-6.74M
EBT including unusual items
309.03M
475.33M
223.22M
297.63M
EBT excluding unusual items
325.86M
459.76M
225.12M
312.34M
Income tax expense
54.37M
105.90M
44.12M
62.16M
Effective tax rate
17.59%
22.28%
19.77%
20.89%
Other operating expenses
-8.80M
43.92M
1.49M
27.07M
Net income
186.12M
272.15M
125.87M
173.04M
Net profit margin
13.74%
15.98%
11.02%
11.90%
Earnings per share
0.10
0.13
0.06
0.08
Interest and investment income
6.38M
3.98M
7.68M
2.02M
Interest expense
-3.23M
-
-1.84M
-
Net interest expenses
3.15M
3.98M
5.84M
2.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
404.25M
552.44M
319.87M
425.66M
Gain or loss from assets sale
204.68K
-104.45K
-
-21.40K
AI content may include mistakes. Learn more
Google apps